✦ LIBER ✦

Active surveillance for intussusception in a phase III efficacy trial of an oral monovalent rotavirus vaccine in India

✍ Scribed by John, Jacob; Kawade, Anand; Rongsen-Chandola, Temsunaro; Bavdekar, Ashish; Bhandari, Nita; Taneja, Sunita; Antony, Kalpana; Bhatnagar, Veereshwar; Gupta, Arun; Kabra, Madhulika; Kang, Gagandeep

Book ID: 125819950
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 789 KB
Volume: 32
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2014.03.036

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of an oral live atte

Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study

✍ Alexandre C Linhares; F Raúl Velázquez; Irene Pérez-Schael; Xavier Sáez-Llorens; 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 130 KB

Efficacy and safety of a modified killed

Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial

✍ Dipika Sur; Anna Lena Lopez; Suman Kanungo; Allison Paisley; Byomkesh Manna; Moh 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 193 KB

The data management of a phase III effic

The data management of a phase III efficacy trial of an 11-valent pneumococcal conjugate vaccine and related satellite studies conducted in the Philippines

✍ Diozele Hazel M Sanvictores, Marilla G Lucero, Hanna Nohynek, Veronica L Tallo, 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 331 KB

A phase III trial of efficacy of the FML

A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (São Gonçalo do Amaranto, RN)

✍ Valdemir Oliveira da Silva; Gulnara P Borja-Cabrera; Nubia N Correia Pontes; Edi 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 293 KB

Efficacy of an oral contraceptive contai

Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara®) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial

✍ Gerd Plewig; William J. Cunliffe; Natascha Binder; Kornelia Höschen 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 346 KB

Evaluation of safety and efficacy as an

Evaluation of safety and efficacy as an adjuvant for the chitosan-based vaccine delivery vehicle ViscoGel in a single-blind randomised Phase I/IIa clinical trial

✍ Neimert-Andersson, Theresa; Binnmyr, Jonas; Enoksson, Mattias; Langebäck, Joakim 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 800 KB